1 Min Read
July 13 (Reuters) -
* FDA grants orphan drug designation to Allena Pharmaceuticals’ investigational therapy for the treatment of primary hyperoxaluria Source text for Eikon:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.